Z-2067-2026 Class II Ongoing

Recalled by BioFire Diagnostics, LLC — Salt Lake City, UT

FDA device recall Z-2067-2026 was initiated by BioFire Diagnostics, LLC on Apr 22, 2026 and is designated Class II. Reason for recall: Contamination to in-vitro diagnostic test may result in false positives. The recall status is ongoing. Affected quantity: 106 kits (3,180 test).

Recall details

Product Type
Devices
Report Date
May 13, 2026
Initiation Date
Apr 22, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
106 kits (3,180 test)

Product description

BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.

Reason for recall

Contamination to in-vitro diagnostic test may result in false positives.

Distribution pattern

Worldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the countries of France, Italy, Germany, Spain, Belgium, Switzerland, United Kingdom, Netherlands, Poland, Austria, India, Finland, Czech Republic, Egypt, Lebanon, Morocco, Slovenia, Romania, Dominican Republic, Serbia.

Code information

Lot #s:0883425,0878825/DI: 00815381020192

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2067-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2067-2026. Report a data issue: hello@regdatalab.com.